Procter & Gamble, US7427181091

Procter & Gamble stock: Goldman raises target to USD 161 for Procter & Gamble stock

Published on 10/23/2026 at 16:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
P&G's P/E is 24.30 on October 23, 2026. Procter & Gamble stock costs EUR 144.42 on October 23, 2026, down 2.85 percent versus the Xetra close.

Analyst target and reporting date

  • Goldman Sachs retained a Neutral rating and cited a USD 150.00 prior target on October 22, 2026.
  • Procter & Gamble reported USD 87.0 billion in fiscal 2026 net sales and USD 19.6 billion in operating cash flow.
  • Procter & Gamble stock costs EUR 144.42 at Lang & Schwarz on October 23, 2026 at 4:34 p.m. CEST, 2.85 percent below the Xetra close of October 22, 2026, and 3.57 percent below its 52-week high.
  • Investor Day is scheduled for November 19, 2026.
Aquarell der Cincinnati Skyline zeigt Sitz der The Procter & Gamble Company, ISIN US7427181091, gemalt, Illustration mit AI erstellt.

Procter & Gamble (ISIN US7427181091) is trading at EUR 144.42 at Lang & Schwarz on October 23, 2026 at 4:34 p.m. CEST, down 2.85 percent versus the Xetra close of October 22, 2026 at EUR 148.66. Goldman Sachs raised its price target from USD 150.00 to USD 161.00 and kept a Neutral rating on October 22, 2026, according to Markets Insider. The target is 0.17 percent below the NYSE price of USD 161.28 at 10:42 a.m. EDT.

Fiscal figures set the baseline

Procter & Gamble's fiscal 2026 net sales reached USD 87.0 billion, up 3.26 percent from USD 84.3 billion in fiscal 2025. Operating cash flow rose to USD 19.6 billion from USD 17.8 billion over the same periods. These figures appear in the company's investor-relations materials for fiscal 2026, which also report 1 percent organic sales growth and 1 percent core earnings-per-share growth.

Stock sits below its yearly high

The NYSE price of USD 161.28 on October 23, 2026 at 10:42 a.m. EDT was 3.57 percent below the 52-week high of USD 167.25 and 17.19 percent above the 52-week low of USD 137.62. The company's market capitalization was USD 374.6 billion and its price-to-earnings ratio was 24.30 at that quote time. The euro quotation moved in the opposite direction from the previous Xetra session as the German listing reflected the broader US decline.

Investor Day follows in November

Procter & Gamble's next scheduled investor date is November 19, 2026, when management plans to hold its Investor Day, as noted in the Benzinga transcript dated October 22, 2026. The event gives investors a scheduled point for deeper discussion of the company's longer-term operating plans.

Comparison with peers

Procter & Gamble: down 1.96 percent on the NYSE in USD, P/E 24.30, market capitalization USD 374.6 billion.

PepsiCo: down 2.32 percent on the NYSE in USD, P/E 17.03, market capitalization USD 184.8 billion.

Colgate-Palmolive: down 3.21 percent on the NYSE in USD, P/E 37.39, market capitalization USD 75.1 billion.

Analyst target meets a weaker quote

Goldman Sachs's USD 161.00 target is close to the NYSE quote, while the euro price remains below the prior Xetra close. The combination leaves the analyst target as a valuation reference and the scheduled Investor Day as the next date for company-specific detail.

The further course of trading is shown by the continuously updated real-time quote of Procter & Gamble stock.

Procter & Gamble market facts

  • Company: The Procter & Gamble Company
  • ISIN: US7427181091
  • Ticker: PG
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 23, 2026, 4:34 p.m. CEST): EUR 144.42
  • Change versus Xetra close: minus 2.85 percent
  • Xetra close (October 22, 2026): EUR 148.66
  • Market capitalization: USD 374.6 billion (as of October 23, 2026)
  • 52-week range: USD 137.62-167.25 (as of October 23, 2026)
  • Sector / Industry: Consumer Defensive / Household and Personal Products

Market context: Market report S&P 500.

More news and analyses on Procter & Gamble stock

Disclaimer...
en | US7427181091 | PROCTER & GAMBLE | boerse | 70400179 | bgmi